ALNYLAM PHARMACEUTICALS, INC. Stock Issued During Period, Value, Restricted Stock Award, Gross
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Stock Issued During Period, Value, Restricted Stock Award, Gross of $2.30 million for the 1-month period ending 2011-05-31, per its 10-K filed 2016-02-12.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross · last filed 2016-02-12
- 2011-05-31: Stock Issued During Period, Value, Restricted Stock Award, Gross 1 month $2.30M.
- 2010-10-31: Stock Issued During Period, Value, Restricted Stock Award, Gross 1 month $1.40M.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 1 month |
|---|---|
| 2011-05-31 | $2.30M 10-K · filed 2016-02-12 |
| 2010-10-31 | $1.40M 10-K · filed 2016-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |